Cargando…

Expression of STAT3-regulated genes in circulating CD4+ T cells discriminates rheumatoid arthritis independently of clinical parameters in early arthritis

OBJECTIVES: Dysregulated signal transduction and activator of transcription-3 (STAT3) signalling in CD4+ T cells has been proposed as an early pathophysiological event in RA. We sought further evidence for this observation, and to determine its clinical relevance. METHODS: Microarray technology was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anderson, Amy E, Maney, Nicola J, Nair, Nisha, Lendrem, Dennis W, Skelton, Andrew J, Diboll, Julie, Brown, Philip M, Smith, Graham R, Carmody, Ruaidhrí J, Barton, Anne, Isaacs, John D, Pratt, Arthur G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587924/ https://www.ncbi.nlm.nih.gov/pubmed/30753680 http://dx.doi.org/10.1093/rheumatology/kez003

Ejemplares similares

CD4+ and B Lymphocyte Expression Quantitative Traits at Rheumatoid Arthritis Risk Loci in Patients With Untreated Early Arthritis: Implications for Causal Gene Identification
por: Thalayasingam, Nishanthi, et al.
Publicado: (2018)

IL-6 Mediated Transcriptional Programming of Naïve CD4+ T Cells in Early Rheumatoid Arthritis Drives Dysregulated Effector Function
por: Ridgley, Laura A., et al.
Publicado: (2019)

Predicting drug-free remission in rheumatoid arthritis: A prospective interventional cohort study
por: Baker, Kenneth F., et al.
Publicado: (2019)

Erratum to “Predicting drug-free remission in rheumatoid arthritis: A prospective interventional cohort study” [J. Autoimmun. 105 (December 2019) 102298]
por: Baker, Kenneth F., et al.
Publicado: (2022)

Lack of association between clinical and ultrasound measures of disease activity in rheumatoid arthritis remission
por: Baker, Kenneth F., et al.
Publicado: (2020)

Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming
por: Cooles, Faye A H, et al.
Publicado: (2022)

Components of treatment delay in rheumatoid arthritis differ according to autoantibody status: validation of a single-centre observation using national audit data
por: Pratt, Arthur G., et al.
Publicado: (2016)

Current concepts in the pathogenesis of early rheumatoid arthritis
por: Pratt, Arthur G., et al.
Publicado: (2009)

The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapy
por: Cooles, Faye A.H., et al.
Publicado: (2018)

Differential DNA methylation correlates with response to methotrexate in rheumatoid arthritis
por: Nair, Nisha, et al.
Publicado: (2020)

IL-6-driven STAT signalling in circulating CD4+ lymphocytes is a marker for early anticitrullinated peptide antibody-negative rheumatoid arthritis
por: Anderson, Amy E, et al.
Publicado: (2016)

Predicting treatment response to IL6R blockers in rheumatoid arthritis
por: Nouri, Bako, et al.
Publicado: (2020)

Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis
por: Bell, G M, et al.
Publicado: (2017)

Lymphocyte DNA methylation mediates genetic risk at shared immune-mediated disease loci
por: Clark, Alexander D., et al.
Publicado: (2020)

Differential Methylation as a Biomarker of Response to Etanercept in Patients With Rheumatoid Arthritis
por: Plant, Darren, et al.
Publicado: (2016)

Phenotypic and Transcriptomic Analysis of Peripheral Blood Plasmacytoid and Conventional Dendritic Cells in Early Drug Naïve Rheumatoid Arthritis
por: Cooles, Faye A. H., et al.
Publicado: (2018)

The Rheumatoid Arthritis and MUScle (RAMUS) Study: Protocol for an observational single-arm study of skeletal muscle in patients with rheumatoid arthritis receiving tofacitinib
por: Bennett, Joshua L., et al.
Publicado: (2023)

Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatment
por: OIiver, James, et al.
Publicado: (2021)

Pharmacogenetics of TNF inhibitor response in rheumatoid arthritis utilizing the two-component disease activity score
por: Gilani, Syed SA, et al.
Publicado: (2020)

STAT6 and STAT1 Pathway Activation in Circulating Lymphocytes and Monocytes as Predictor of Treatment Response in Rheumatoid Arthritis
por: Kuuliala, Krista, et al.
Publicado: (2016)

What are the dominant cytokines in early rheumatoid arthritis?
por: Ridgley, Laura A., et al.
Publicado: (2018)

Correction to: Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatment
por: Oliver, James, et al.
Publicado: (2021)

Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies
por: Cooles, Faye A. H., et al.
Publicado: (2016)

Negative Regulators of JAK/STAT Signaling in Rheumatoid Arthritis and Osteoarthritis
por: Malemud, Charles J.
Publicado: (2017)

Raised circulating tenascin-C in rheumatoid arthritis
por: Page, Theresa H, et al.
Publicado: (2012)

Association between social deprivation and disease activity in rheumatoid arthritis: a systematic literature review
por: Dey, Mrinalini, et al.
Publicado: (2022)

JAK/STAT pathway in pathology of rheumatoid arthritis (Review)
por: Ciobanu, Dana Alexandra, et al.
Publicado: (2020)

Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomics
por: Maciejewski, Mateusz, et al.
Publicado: (2021)

A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative disease
por: Pratt, Arthur G, et al.
Publicado: (2012)

Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritis
por: Hum, Ryan M, et al.
Publicado: (2022)

Profiling of Gene Expression Biomarkers as a Classifier of Methotrexate Nonresponse in Patients With Rheumatoid Arthritis
por: Plant, Darren, et al.
Publicado: (2019)

Circulating levels of IL-7 in rheumatoid arthritis
por: Churchman, S, et al.
Publicado: (2007)

14.5 Rheumatoid Arthritis susceptibility loci; STAT4, TRAF1/C5 and 6q23 region, are also associated with Juvenile Idiopathic Arthritis
por: Hinks, A, et al.
Publicado: (2008)

Stat3 as a potential therapeutic target for rheumatoid arthritis
por: Oike, Takatsugu, et al.
Publicado: (2017)

Predicting persistent inflammatory arthritis amongst early arthritis clinic patients in the UK: is musculoskeletal ultrasound required?
por: Pratt, Arthur G, et al.
Publicado: (2013)

Roles of B cells in rheumatoid arthritis
por: Silverman, Gregg J, et al.
Publicado: (2003)

Proteomic analysis to define predictors of treatment response to adalimumab or methotrexate in rheumatoid arthritis patients
por: Ling, Stephanie F., et al.
Publicado: (2019)

Circulating IL-27 Is Elevated in Rheumatoid Arthritis Patients
por: Lai, Xiaofei, et al.
Publicado: (2016)

Molecular Characterization of Circulating Microbiome Signatures in Rheumatoid Arthritis
por: Hammad, Dargham B. M., et al.
Publicado: (2020)

Circulating Biomarkers and Cardiac Structure and Function in Rheumatoid Arthritis
por: Kobayashi, Masatake, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9c3fhj9h2th6s68er4ketil603